XML 68 R52.htm IDEA: XBRL DOCUMENT
v3.25.4

Earnings per Share (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Earnings Per Share [Abstract] |
Schedule of computation of basic and diluted earnings per share | The following table sets forth the income attributable to the Company from continuing operations, net of tax, and the Company’s common shares outstanding, and its participating securities outstanding. There were no contractual dividends paid for the years ended December 31, 2023, 2024, and 2025.
|  |  |  | Basic and Diluted EPS
|  |  |  | For the Year Ended December 31,
|  |  |  |  |  |  |  | 2023 |  | 2024 |  | 2025
|  |  |  |  |  |  | (in thousands)
Income from continuing operations, net of tax |  |  |  |  |  |  |  | $ | 110,471 |  |  | $ | 129,987 |  |  | $ | 214,533 |
Less: net income attributable to non-controlling interests |  |  |  |  |  |  |  | 51,444 |  |  | 64,514 |  |  | 68,314 |
Income from continuing operations, net of tax, attributable to Select Medical’s common stockholders |  |  |  |  |  |  |  | 59,027 |  |  | 65,473 |  |  | 146,219 |
Less: distributed and undistributed net income attributable to participating securities |  |  |  |  |  |  |  | 2,127 |  |  | 2,319 |  |  | 3,354 |
Distributed and undistributed income from continuing operations, net of tax, attributable to common shares |  |  |  |  |  |  |  | $ | 56,900 |  |  | $ | 63,154 |  |  | $ | 142,865 |
The following tables set forth the computation of EPS under the two-class method:
|  | For the Year Ended December 31, 2023
|  | Income from Continuing Operations, Net of Tax, Allocation |  | Shares(1) |  | Basic and Diluted EPS
|  | (in thousands, except for per share amounts)
Common shares |  | $ | 56,900 |  |  | 123,105 |  |  | $ | 0.46 |
Participating securities |  | 2,127 |  |  | 4,601 |  |  | 0.46 |
Total Company |  | $ | 59,027 |  |  |  |  |
|  | For the Year Ended December 31, 2024
|  | Income from Continuing Operations, Net of Tax, Allocation |  | Shares(1) |  | Basic and Diluted EPS
|  | (in thousands, except for per share amounts)
Common shares |  | $ | 63,154 |  |  | 124,614 |  |  | $ | 0.51 |
Participating securities |  | 2,319 |  |  | 4,576 |  |  | 0.51 |
Total Company |  | $ | 65,473 |  |  |  |  |
|  | For the Year Ended December 31, 2025
|  | Income from Continuing Operations, Net of Tax, Allocation |  | Shares(1) |  | Basic and Diluted EPS
|  | (in thousands, except for per share amounts)
Common shares |  | $ | 142,865 |  |  | 122,647 |  |  | $ | 1.16 |
Participating securities |  | 3,354 |  |  | 2,879 |  |  | $ | 1.16 |
Total Company |  | $ | 146,219 |  |  |  |  |
_______________________________________________________________________________ (1) Represents the weighted average share count outstanding during the period.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration